News

The European Medicines Agency has issued a warning that falsified diabetes medicine has been found in the European Union and the United Kingdom. Therefore, the Latvian Medicines Verification Organization urges residents to purchase medicine only at legal public and online pharmacies.

In 2019 the Polish Medicines Verification Organization (PLMVO) have implemented a robust verification system, which is a part of European Medicines Verification System (EMVS) in European Union. The Polish Medicines Verification System (PLMVS) plays a crucial role in ensuring the safety and authenticity of medicines in the supply chain in Poland.

The German Federal Institute for Medicines and Medical Devices (BfArM) has confirmed that the medicines verification system in Germany has detected a counterfeit versions of medicine Ozempic®, which were promptly removed from circulation and has not reached the patients.

Intermarket transactions (IMTs) are a core part of the EMVS but present their own unique challenges.

The Latvian Medicines Verification Organization (LZVO) is launching The Newsletter No. 6, where you can find the most important information about events in the world of medicines verification in the second quarter of 2023.

The European Medicines Verification Organisation (EMVO) has launched a newsletter, which informs about the statement from EMVO’s new President, the roles and responsibilities of the National Medicines Verification Organisations (NMVO) Observers, the experience from the Hungarian Medicines Verification Organisation in ending the stabilisation period, the Belgium's experience with the Nordic recommendations on the recalls of batches and withdrawal of products, as well as on the status of alerts in the European Medicines Verification System (EMVS).